LD-2 disclosure · 1st Quarter - Report
ADAPTIVE BIOTECHNOLOGIES
Client
- Description
- Biotechnology company focusing on immune-driven medicine
- Location
- Washington · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
LobbyistsKRISTINE BLACKWOOD · PARI MODY · EUGENIA PIERSON · BOBBY MCMILLIN · ms NATALIE TIETJEN · mr PETER ERIC DUYSHART
Covered position (ms NATALIE TIETJEN): Intern, Rep. Watson Coleman (2018)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)
Health Issues
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
LobbyistsKRISTINE BLACKWOOD · PARI MODY · EUGENIA PIERSON · BOBBY MCMILLIN · ms NATALIE TIETJEN · mr PETER ERIC DUYSHART
Covered position (ms NATALIE TIETJEN): Intern, Rep. Watson Coleman (2018)
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)